WallStreetZenWallStreetZen

AnalystsAdam Maeder
Adam Maeder's Stock Forecasts

Analyst Ranking
Top 18%
#776 out of 4337 analysts
Average Return
+5.89%
Win Rate
42%22 out of 52
Risk vs Reward
Poor
Good

Adam Maeder's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Inspire Medical Systems IncINSP
+238.11%$64.61$218.45
2020-04-09 -
2021-04-09
Strong Buy
Tactile Systems Technology IncTCMD
+149.02%$9.16$22.81
2022-08-02 -
2023-08-01
Strong Buy
Inspire Medical Systems IncINSP
+96.50%$126.85$249.26
2020-09-18 -
2021-09-17
Strong Buy
Inspiremd IncNSPR
+78.02%$1.82$3.24
2023-06-12 -
2023-09-22
Strong Buy
Apollo Endosurgery IncAPEN
+68.40%$4.81$8.10
2020-11-30 -
2021-11-29
Strong Buy

Adam Maeder's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Edwards Lifesciences CorpEW
8Hold$83.00+19.15%Maintains
16 days ago
Nyxoah SaNYXH
5Strong Buy$11.00+50.68%Maintains
a month ago
Inspiremd IncNSPR
1Strong Buy$3.00-7.41%Initiates Coverage On
3 months ago
Silk Road Medical IncSILK
3Hold$41.00+160.98%Maintains
4 months ago
Tactile Systems Technology IncTCMD
2Strong Buy$30.00+131.66%Maintains
4 months ago
Shockwave Medical IncSWAV
6Strong Buy$315.00+61.97%Maintains
4 months ago
Nevro CorpNVRO
10Strong Sell$34.00+76.35%Maintains
5 months ago
Stereotaxis IncSTXS
2Strong Buy$5.00+197.62%Maintains
7 months ago
Inspire Medical Systems IncINSP
10Strong Buy$305.00+64.86%Maintains
8 months ago
Zynex IncZYXI
2Strong Buy$18.00+113.52%Upgrades
9 months ago
Intuitive Surgical IncISRG
10Strong Buy$265.00-8.05%Maintains
a year ago
Axonics IncAXNX
4Strong Buy$84.00+53.01%Maintains
a year ago
Inari Medical IncNARI
1Strong Buy$100.00N/AInitiates Coverage On
a year ago
Vicarious Surgical IncRBOT
3Hold$5.00N/AMaintains
a year ago
Livanova PLCLIVN
3Strong Buy$99.00N/AMaintains
a year ago
Apollo Endosurgery IncAPEN
4Strong Buy$11.00N/AMaintains
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.